Skip to search formSkip to main contentSkip to account menu

Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Known as: CNS DLBCL, Central Nervous System Diffuse Large B-Cell Lymphoma, Primary DLBCL of the CNS 
A diffuse large B-cell lymphoma arising from the central nervous system.
National Institutes of Health

Related topics

Related topics

18 relations
Atypical lymphocyteB lymphoblastB-LymphocytesBCL6 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
High tumoral PD-L1 expression and low PD-1+ or CD8+ tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system
ABSTRACT We investigated the clinicopathological role of the PD-1/PD-L1 pathway in primary diffuse large B-cell lymphoma of the… 
2019
2019
Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas
Primary central nervous system diffuse large B cell lymphoma (PCNS-DLBCL) is a rare and aggressive entity of diffuse large B cell… 
2017
2017
Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B‐cell lymphoma
Primary CNS diffuse large B‐cell lymphoma (PCNS‐DLBCL) and systemic DLBCL harbor mutations in MYD88 and CD79B. DNA… 
Highly Cited
2016
Highly Cited
2016
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
Purpose: MYD88 mutations, notably the recurrent gain-of-function L265P variant, are a distinguishing feature of activated B-cell… 
2016
2016
Treatment of diffuse large B‐cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS‐penetrating R‐IDARAM chemotherapy
Diffuse large B‐cell lymphoma with secondary involvement of the central nervous system (SCNS‐DLBCL) is a rare condition carrying… 
2016
2016
FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism
Molecular profiling has led to identification of subtypes of diffuse large B-cell lymphomas (DLBCLs) differing in terms of… 
Highly Cited
2012
Highly Cited
2012
Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma
Primary gastrointestinal (PGI) diffuse large B cell lymphoma (DLBCL) is a relatively common disease. Recent studies indicate that… 
Review
2009
Review
2009
Primary lymphoma of the central nervous system: just DLBCL or not?
Primary lymphoma of the central nervous system (PCNSL), defined as diffuse large B-cell lymphoma (DLBCL) confined to the central… 
2009
2009
The therapeutic effect of rituximab on CD5‐positive and CD5‐negative diffuse large B‐cell lymphoma
The prognosis of diffuse large B‐cell lymphoma (DLBCL) has improved markedly in recent years of rituximab era. The prognosis of… 
2007
2007
A phase II study of a THP‐COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B‐cell lymphoma
Pirarubicin (tetrahydropyranyl adriamycin: THP) is an anthracycline drug that reportedly has fewer cardiotoxic effects than… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)